Implementing differential recovery corrections enhances accuracy of mass balances on microplastics in wastewater treatment.

Water Res

Department of Civil & Environmental Engineering, University of Waterloo, 200 University Avenue West, Waterloo, Ontario, Canada, N2L 3G1.

Published: December 2024

This study examined the impact of using different analytical recovery practices to correct MP concentrations on the performance of count and mass balances of primary wastewater settling. Spiking tests using standard MPs were conducted to evaluate the influence of MP size and sample type on recovery. The derived recovery values were then used to correct MP concentrations and loads in a full-scale primary treatment facility. The results reveal substantial differences in recovery that were dependent upon MP size and sample type, underlining the necessity of incorporating these discrepancies when estimating MP concentrations. Omitting recovery considerations during MP concentration reporting led to underestimations of approximately 40 %. In contrast, incorporating MP size and sample type during recovery calculations fostered a more accurate representation of MP concentrations, thereby enhancing the closure of balance models. While a count balance model was not apparently improved through the use differential recovery, the mass balance model showed a significant improvement in closure, reducing the lack of balance from 30.2 % to 17.2 %. This discrepancy was primarily attributed to the differing proportions of the primary sludge stream load in each model. These findings highlight the importance of incorporating differential recovery into mass balance models and demonstrate the complementary nature of count and mass balance approaches in understanding the fate and transport of MPs in WWTPs. The results of this study have significant implications for improving environmental assessments, policies and engineering design of wastewater treatment processes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.watres.2024.122912DOI Listing

Publication Analysis

Top Keywords

differential recovery
12
size sample
12
sample type
12
mass balance
12
recovery
9
mass balances
8
wastewater treatment
8
correct concentrations
8
count mass
8
type recovery
8

Similar Publications

Growth-differentiation factor 15 (GDF-15) is a cytokine involved in cellular stress responses and inflammation. This meta-analysis evaluates the association between circulating GDF-15 levels and functional outcomes in patients with acute ischemic stroke (AIS). A comprehensive search of Medline, Web of Science, Embase, Wanfang, and CNKI was conducted up to July 15, 2024.

View Article and Find Full Text PDF

Decoding Brain Development and Aging: Pioneering Insights From MRI Techniques.

Invest Radiol

October 2024

From the Department of Radiology, Juntendo University School of Medicine, Tokyo, Japan (A.H., S.K., J.K., M.N., W.U., S.F., T.A., A.W., K.K., S.A.); Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan (A.H., M.N., S.F.); Polytechnique Montréal, Montreal, Quebec, Canada (S.N.); Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada (S.N.); and Center for Advanced Interdisciplinary Research, Ss. Cyril and Methodius University in Skopje, Skopje, North Macedonia (S.N.).

The aging process induces a variety of changes in the brain detectable by magnetic resonance imaging (MRI). These changes include alterations in brain volume, fluid-attenuated inversion recovery (FLAIR) white matter hyperintense lesions, and variations in tissue properties such as relaxivity, myelin, iron content, neurite density, and other microstructures. Each MRI technique offers unique insights into the structural and compositional changes occurring in the brain due to normal aging or neurodegenerative diseases.

View Article and Find Full Text PDF

Nitric Oxide-Releasing Mesoporous Hollow Cerium Oxide Nanozyme-Based Hydrogel Synergizes with Neural Stem Cell for Spinal Cord Injury Repair.

ACS Nano

December 2024

Department of Pharmacy, Nanjing Medical Center for Clinical Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China.

Neural stem cell (NSCs) transplantation is a promising therapeutic strategy for spinal cord injury (SCI), but its efficacy is greatly limited by the local inhibitory microenvironment. In this study, based on l-arginine (l-Arg)-loaded mesoporous hollow cerium oxide (AhCeO) nanospheres, we constructed an injectable composite hydrogel (AhCeO-Gel) with microenvironment modulation capability. AhCeO-Gel protected NSCs from oxidative damage by eliminating excess reactive oxygen species while continuously delivering Nitric Oxide to the lesion of SCI in a pathological microenvironment, the latter of which effectively promoted the neural differentiation of NSCs.

View Article and Find Full Text PDF

Targeting Remyelination in Spinal Cord Injury: Insights and Emerging Therapeutic Strategies.

CNS Neurosci Ther

December 2024

Central Laboratory of The Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, Zhejiang, China.

Article Synopsis
  • Spinal cord injury (SCI) is a major neurological disorder causing serious motor, sensory, and autonomic issues, primarily due to poor axon regeneration and remyelination.
  • Recent research highlights new therapeutic strategies that target key molecules and pathways to enhance myelin repair in SCI, using both lab and animal studies.
  • The review emphasizes the challenges in applying these findings to clinical settings, focusing on safety and delivery methods, while positing targeted remyelination therapies as a hopeful treatment approach for SCI.
View Article and Find Full Text PDF

Adequate hypothermic storage of human mesenchymal stem cells (hMSCs) is of fundamental importance since they have been explored in several regenerative medicine initiatives. However, the actual clinical application of hMSCs necessitates hypothermic storage for long periods, a process that requires the use of non-toxic and efficient cryo-reagents capable of maintaining high viability and differentiating properties after thawing. Current cryopreservation methods are based on cryoprotectant agents (CPAs) containing dimethylsulphoxide (DMSO), which have been shown to be toxic for clinical applications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!